Wellington Management Group LLP Invests $1.89 Million in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Wellington Management Group LLP acquired a new position in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 14,314 shares of the medical instruments supplier's stock, valued at approximately $1,888,000. Wellington Management Group LLP owned about 0.26% of Mesa Laboratories as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Mesa Laboratories by 20.3% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 10,103 shares of the medical instruments supplier's stock valued at $1,312,000 after purchasing an additional 1,708 shares during the last quarter. Barclays PLC grew its holdings in Mesa Laboratories by 357.4% during the third quarter. Barclays PLC now owns 8,837 shares of the medical instruments supplier's stock valued at $1,148,000 after purchasing an additional 6,905 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Mesa Laboratories by 4.8% in the third quarter. Geode Capital Management LLC now owns 124,761 shares of the medical instruments supplier's stock valued at $16,205,000 after purchasing an additional 5,771 shares during the period. Franklin Resources Inc. lifted its stake in shares of Mesa Laboratories by 27.8% in the third quarter. Franklin Resources Inc. now owns 6,444 shares of the medical instruments supplier's stock worth $828,000 after buying an additional 1,403 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its holdings in shares of Mesa Laboratories by 21.8% during the 3rd quarter. Principal Financial Group Inc. now owns 35,107 shares of the medical instruments supplier's stock worth $4,559,000 after buying an additional 6,292 shares during the period. Institutional investors own 90.60% of the company's stock.

Remove Ads

Mesa Laboratories Stock Performance

MLAB traded up $1.43 during trading on Tuesday, hitting $115.52. The stock had a trading volume of 45,405 shares, compared to its average volume of 38,874. The firm has a market cap of $627.74 million, a PE ratio of -2.50 and a beta of 0.92. The company has a current ratio of 0.71, a quick ratio of 0.53 and a debt-to-equity ratio of 0.61. Mesa Laboratories, Inc. has a 12 month low of $83.68 and a 12 month high of $155.12. The company has a 50 day simple moving average of $129.21 and a 200-day simple moving average of $128.02.

Mesa Laboratories (NASDAQ:MLAB - Get Free Report) last posted its quarterly earnings data on Tuesday, February 4th. The medical instruments supplier reported $2.07 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.66. Mesa Laboratories had a positive return on equity of 30.23% and a negative net margin of 104.92%. Analysts expect that Mesa Laboratories, Inc. will post 8 EPS for the current year.

Mesa Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Friday, May 30th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.55%. The ex-dividend date of this dividend is Friday, May 30th. Mesa Laboratories's payout ratio is currently -1.38%.

Insider Buying and Selling at Mesa Laboratories

In other Mesa Laboratories news, CEO Gary M. Owens sold 21,000 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $123.91, for a total value of $2,602,110.00. Following the completion of the transaction, the chief executive officer now owns 43,337 shares of the company's stock, valued at $5,369,887.67. This represents a 32.64 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 4.40% of the company's stock.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.